LSI USA '26 Filling Fast:
Register Today

News

Join LSI USA ‘27

20 03 24_LSI_DAY_2_(ADAM) 0384

FDA Breakthrough Device Designation: ROI and Considerations With Shifts in Coverage

At a panel at LSI USA '24, industry experts gathered to share their perspectives on FDA Breakthrough Device...

104 LSI USA24 DAY 2 EVE large

BCI Technologies: Neurotechnology to Address Limitations of the Human Body

At a panel at LSI USA '24, the discussion around brain-computer interfaces (BCIs) highlighted their transfo...

20 03 24 LSI DAY 2 (ADAM) 0787 large

International Expansion, Market Development, and Cross-Border Partnerships in the US, EU, and APAC | Insights from LSI USA ‘24

LSI Track 4 Day 2 512 large

Harsh Realities in Building and Financing Medtech Ventures | Insights from LSI USA ‘24

LSI Track 4 Day 3 492 large

Insights from LSI USA ‘24 | Investing for the Long-Haul: Supporting Companies and Aligning Investors Across Stages

LSI Track 4 Day 3 534 large

Insights from LSI USA ‘24: What Does 2024 Hold For the Frozen IPO Market?

insights from lsi usa 24 ip friend or foe in building medtech ventures

Insights from LSI USA ‘24 | IP: Friend or Foe in Building Medtech Ventures?

LSI Track 4 Day 3 109 large

Insights from LSI USA '24: The Verticalization of AI in Medtech and Healthcare

blog

Insights from LSI USA '24: The Agony and Ecstasy of Doing Big Things in Medtech

lab_to_market

Insights From LSI USA ‘24: Bridging the Gap Between Academia and Industry

medtech_investors_lsi_usa

Insights From LSI USA ‘24: Medtech Growth Capital and the New Normal in Late-Stage Financing

medtech_ma_USA_24

Insights From LSI USA ‘24: Medtech M&A 2024, Looking Onward and Upward

‹
1
2
3
4
5
›